BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33335784)

  • 21. Extraoral plasmablastic lymphoma with intravascular component and MYC translocation.
    Chapman-Fredricks J; Montague N; Akunyili I; Ikpatt O
    Ann Diagn Pathol; 2012 Jan; 16(1):48-53. PubMed ID: 21239197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
    Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
    J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
    Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
    Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
    Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
    J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD3-positive plasmablastic lymphoma reported in two cases: A potential diagnostic caveat.
    Wong YP; Masir N; Chew MX
    Indian J Pathol Microbiol; 2021; 64(3):579-583. PubMed ID: 34341278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
    Landsburg DJ; Falkiewicz MK; Petrich AM; Chu BA; Behdad A; Li S; Medeiros LJ; Cassaday RD; Reddy NM; Bast MA; Vose JM; Kruczek KR; Smith SE; Patel P; Hernandez-Ilizaliturri F; Karmali R; Rajguru S; Yang DT; Maly JJ; Blum KA; Zhao W; Vanslambrouck C; Nabhan C
    Br J Haematol; 2016 Nov; 175(4):631-640. PubMed ID: 27469075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmablastic lymphoma of the oral cavity in a human immunodeficiency virus-negative patient: a case report with literature review.
    Choi SY; Cho YA; Hong SD; Lee JI; Hong SP; Yoon HJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):e115-20. PubMed ID: 23791544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 expression in large B-cell lymphomas with MYC extra copies and CD99 expression in large B-cell lymphomas in relation to MYC status.
    Richardson AI; Zhang D; Woodroof J; Cui W
    Hum Pathol; 2019 Apr; 86():21-31. PubMed ID: 30496802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term remission in a case of plasmablastic lymphoma treated with COMP (cyclophosphamide, liposomal doxorubicin, vincristine, prednisone) and bortezomib.
    Cencini E; Fabbri A; Guerrini S; Mazzei MA; Rossi V; Bocchia M
    Eur J Haematol; 2016 Jun; 96(6):650-654. PubMed ID: 26715026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmablastic lymphoma of the small intestine: case report and literature review.
    Wang HW; Yang W; Sun JZ; Lu JY; Li M; Sun L
    World J Gastroenterol; 2012 Dec; 18(45):6677-81. PubMed ID: 23236245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement.
    Ouansafi I; He B; Fraser C; Nie K; Mathew S; Bhanji R; Hoda R; Arabadjief M; Knowles D; Cerutti A; Orazi A; Tam W
    Am J Clin Pathol; 2010 Dec; 134(6):972-81. PubMed ID: 21088162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmablastic Lymphoma Presenting as Extensive Peritoneal and Retroperitoneal Nodules in an HIV-Positive Patient.
    Pokhrel A; Yuldasheva O; Mirashi E; Nair K; Salyana M; Jaswani V; Avezbakiyev B; Wang JC
    J Investig Med High Impact Case Rep; 2022; 10():23247096211065633. PubMed ID: 35073776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmablastic lymphoma: current perspectives.
    Lopez A; Abrisqueta P
    Blood Lymphat Cancer; 2018; 8():63-70. PubMed ID: 31360094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular histogenesis of plasmablastic lymphoma of the oral cavity.
    Gaidano G; Cerri M; Capello D; Berra E; Deambrogi C; Rossi D; Larocca LM; Campo E; Gloghini A; Tirelli U; Carbone A
    Br J Haematol; 2002 Dec; 119(3):622-8. PubMed ID: 12437635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal Plasmablastic Lymphoma in an HIV-Negative Immunocompetent Patient.
    Shakri NM; Husain S; Zahedi FD; Tan GC
    Medeni Med J; 2020; 35(1):71-74. PubMed ID: 32733753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study.
    Xu PP; Zhong HJ; Huang YH; Gao XD; Zhao X; Shen Y; Cheng S; Huang JY; Chen SJ; Wang L; Zhao WL
    EBioMedicine; 2017 Feb; 16():106-114. PubMed ID: 28153771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmablastic lymphoma in an elderly immunocompetent patient.
    Takeuchi M; Ogawa F; Onishi T; Moriyama Y
    Pathol Int; 2012 May; 62(5):347-50. PubMed ID: 22524665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.
    Savage KJ; Johnson NA; Ben-Neriah S; Connors JM; Sehn LH; Farinha P; Horsman DE; Gascoyne RD
    Blood; 2009 Oct; 114(17):3533-7. PubMed ID: 19704118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Significance of
    Rosenwald A; Bens S; Advani R; Barrans S; Copie-Bergman C; Elsensohn MH; Natkunam Y; Calaminici M; Sander B; Baia M; Smith A; Painter D; Pham L; Zhao S; Ziepert M; Jordanova ES; Molina TJ; Kersten MJ; Kimby E; Klapper W; Raemaekers J; Schmitz N; Jardin F; Stevens WBC; Hoster E; Hagenbeek A; Gribben JG; Siebert R; Gascoyne RD; Scott DW; Gaulard P; Salles G; Burton C; de Jong D; Sehn LH; Maucort-Boulch D
    J Clin Oncol; 2019 Dec; 37(35):3359-3368. PubMed ID: 31498031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.